Navigation Links
Raj Khankari Named Bioenergy, Inc., CEO
Date:7/16/2008

MINNEAPOLIS, July 16 /PRNewswire/ -- In a statement released today, Bud Hayden, a director serving as interim CEO of Bioenergy, Inc., a privately held Minneapolis-based integrative life science company, announced Raj Khankari, PhD, will join the company as its new CEO on August 1, 2008.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080716/AQW501)

Dr. Khankari joins the company from CIMA Labs Inc., a Cephalon company, where he served as General Manager, CIMA Labs Inc., and Vice President for Worldwide Drug Delivery Technologies. Dr. Khankari earned his initial degrees in Pharmaceutics from universities in India. Dr. Khankari also has a PhD in Pharmaceutics and an MBA from the University of Minnesota.

In addition to holding several patents, Dr. Khankari has been widely published in several peer reviewed journals and has been a presenter at more than two dozen national and international meetings.

In making the announcement, Mr. Hayden stated, "We are very pleased to have Dr. Khankari head up our Company. His scientific background, including his successful track record in working with the Food and Drug Administration (FDA) on new product discoveries, in conjunction with the experience he gained in holding senior management positions, will provide the leadership Bioenergy needs to take advantage of our strong intellectual property portfolio."

In addition to its pharmaceutical subsidiary company, Bioenergy has two other subsidiaries. Bioenergy Life Science, Inc. manufactures and sells D-ribose as an ingredient to nutraceuticals firms marketing beverages and foods, as a medical food through doctors and clinics and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is engaged in developing technology related to the enhancement of blood components.

D-Ribose is a naturally occurring monosaccharide the body uses to stimulate the synthesis of adenosine triphosphate (ATP), an essential energy compound. ATP is critical to health and maintaining normal energy-dependent body functions. Ribose is an essential component in the cellular production of ATP.

D-Ribose has been shown to increase functional capacity for patients with congestive heart failure (CHF) by improving diastolic heart function, ventilation, exercise capacity, and oxygen uptake efficiency. It's also widely used to help treat Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS). D-ribose is commonly found in more and more functional foods like energy bars (e.g., Detour, FastFuel, Marathon) and drinks (e.g., Vitamin Water, SoBe Life Water, Snapple Antioxidant Water).

Bioenergy, Inc. (http://www.bioenergy.com) is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose in health and wellness.


'/>"/>
SOURCE Bioenergy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Samarion CEO Mark Rodgers Named CAST Commissioner
2. North Carolina Marketing Firm MicroMass Named One of Top 60 Healthcare Agencies in U.S.
3. Quintiles Named to Computerworld Magazines 100 Best Places to Work in Information Technology List
4. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
5. Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area
6. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
7. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
8. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
9. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
10. Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association
11. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... light to control cells — optogenetics — is key to exciting advances in ... the art, spatially patterned light projected via free-space optics stimulates small, transparent organisms ...
(Date:12/8/2016)... , December 8, 2016 ... für Molekulargenetik, erweitert seine Palette an anpassbaren SureSeq™ ... Custom FH Panels, das ein schnelles und kostengünstiges ... Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single ... mit einem einzigen kleinen Panel und ermöglicht eine ...
(Date:12/8/2016)... Dec. 8, 2016  Anaconda BioMed S.L., a pre-clinical ... the next generation neuro-thrombectomy system for the treatment of ... G. Jovin, MD to join its Scientific Advisory Board ... strategic network of scientific and clinical experts to Anaconda ... the ANCD BRAIN ® to its clinical phase. ...
Breaking Biology Technology:
(Date:6/27/2016)... 2016 Research and Markets has announced the ... report to their offering. The ... to grow at a CAGR of 12.28% during the period ... an in-depth market analysis with inputs from industry experts. The report ... years. The report also includes a discussion of the key vendors ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
Breaking Biology News(10 mins):